Stockreport

Bioventus announces divestiture of its Advanced Rehabilitation business to Accelmed Partners [Seeking Alpha]

Bioventus Inc. - Class A  (BVS) 
PDF The transaction includes a total cash consideration of $45 million, including $25 million in cash at close and up to $20 million in potential post-closing earn-out paym [Read more]